Metabotropic glutamate receptors in the basal ganglia motor circuit
- 1 October 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 6 (10) , 787-798
- https://doi.org/10.1038/nrn1763
Abstract
In recent years there have been tremendous advances in our understanding of the circuitry of the basal ganglia and our ability to predict the behavioural effects of specific cellular changes in this circuit on voluntary movement. These advances, combined with a new understanding of the rich distribution and diverse physiological roles of metabotropic glutamate receptors in the basal ganglia, indicate that these receptors might have a key role in motor control and raise the exciting possibility that they might provide therapeutic targets for the treatment of Parkinson's disease and related disorders.Keywords
This publication has 141 references indexed in Scilit:
- Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid‐induced striatal toxicity: involvement of pre‐ and post‐synaptic mechanisms and lack of direct NMDA blocking activityJournal of Neurochemistry, 2004
- Mechanism of Regulation of Casein Kinase I Activity by Group I Metabotropic Glutamate ReceptorsJournal of Biological Chemistry, 2002
- Dopamine Modulates the Function of Group II and Group III Metabotropic Glutamate Receptors in the Substantia Nigra Pars ReticulataThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Mechanisms and functions of eph and ephrin signallingNature Reviews Molecular Cell Biology, 2002
- Published by Elsevier ,2001
- Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neuronsJournal of Comparative Neurology, 1995
- Glutamatergic drugs in Parkinson's diseaseLife Sciences, 1994
- (+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in miceBrain Research, 1994
- Inhibition of Succinate Dehydrogenase by Malonic Acid Produces an “Excitotoxic” Lesion in Rat StriatumJournal of Neurochemistry, 1993
- Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamineBrain Research, 1980